Screening for Cervical Cancer This article reviews recent evidence from the International
Agency for Research on Cancer on the best methods of screening for cervical cancer …

Cervical cancer is the fourth most common malignancy diagnosed in women worldwide.
Nearly all cases of cervical cancer result from infection with the human papillomavirus, and …

Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

Since the publication of the last FIGO Cancer Report there have been giant strides in the
global effort to reduce the burden of cervical cancer, with WHO announcing a call for …

Importance The number of deaths from cervical cancer in the United States has decreased
substantially since the implementation of widespread cervical cancer screening and has …

Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

In 2011, the American Cancer Society, the American Society for Colposcopy and Cervical
Pathology, and the American Society for Clinical Pathology updated screening guidelines …

Background In four randomised trials, human papillomavirus (HPV)-based screening for
cervical cancer was compared with cytology-based cervical screening, and precursors of …

Importance There is limited information about the relative effectiveness of cervical cancer
screening with primary human papillomavirus (HPV) testing alone compared with cytology in …

Importance Cervical cancer can be prevented with detection and treatment of precancerous
cell changes caused primarily by high-risk types of human papillomavirus (hrHPV), the …